Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 4, 2007, Pages 925-931

  Monaco, Mario ^a   Stassano, Paolo ^a   Di Tommaso, Luigi ^a   Iannelli, Gabriele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DESCENDING AORTA; ENDOLEAK; ENDOVASCULAR SURGERY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; STENT; THORACIC AORTA ANEURYSM;

AGED; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; STATISTICS, NONPARAMETRIC; STENTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548857619     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.05.044     Document Type: Article

References (25)

1. Elefteriades J.A. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 74 Suppl (2002) S1877-S1880 discussion S1892-8
2. Zipes D.P., Libby P., Bonow R.O., and Brauwald E. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition (2005), Elsevier Saunders, Philadelphia
3. Lijnen H.R. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86 (2001) 324-333
4. Elmore J.R., Keister B.F., Franklin D.P., Youkey J.R., and Carey D.J. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysm. Ann Vasc Surg 12 (1998) 221-228
5. Keeling W.B., Armstrong P.A., Stone P.A., Bandyk D.F., and Shames M.L. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 39 (2005) 457-464
6. Sangiorgi G., D'Averio R., Mauriello A., Bondio M., Postillo M., Castelvecchio S., et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 104 Suppl I (2001) I-288-I-295
7. Taurino M., Visco V., Raffa S., Ricci B., Ruggiero M., Torrisi M.R., et al. Matrix metalloproteinase 9 activity in patients before and after endovascular or surgical repair of abdominal aortic aneurysms. Vascular 12 (2004) 312-317
8. Carrell T.W., Burnand K.G., Wells G.M., Clements J.M., and Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105 (2002) 477-482
9. Chen L., Wang X., Carter S.A., Shen Y.H., Bartsch H.R., Thompson R.W., et al. A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg 131 (2006) 1045-1052
10. Koullias G.J., Ravichandran P., Korkolis D.P., Rimm D.L., and Elefteriades J.A. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78 (2004) 2106-2110
11. Boyum J., Fellinger E.K., Schmoker J.D., Trombley L., McPartland K., Ittleman F.P., et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 127 (2004) 686-691
12. Schmoker J.D., McPartland K.J., Fellinger E.K., Boyum J., Trombley L., Ittleman F.P., et al. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms. J Thorac Cardiovasc Surg 133 (2007) 155-161
13. Magi E. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 78 (1997) 228
14. Monaco M., Di Tommaso L., Stassano P., Smimmo R., De Amicis V., Pantaleo A., et al. Impact of blood coagulation and fibrinolytic system changes on early and mid term clinical outcome in patients undergoing stent endografting surgery. Interact CardioVasc Thorac Surg 5 (2006) 724-728
15. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
16. Newman K.M., Ogata Y., Malon A.M., Irizarry E., Gandhi R.H., Nagase H., et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14 (1994) 1315-1320
17. Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96 (1995) 318-326
18. McMillan W.D., Tamarina N.A., Cipollone M., Johnson D.A., Parker M.A., and Pearce W.H. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 96 (1997) 2228-2232
19. Tamarina N.A., McMillan W.D., Shively V.P., and Pearce W.H. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122 (1997) 264-271
20. Ikonomidis J.S., Gibson W.C., Butler J.E., McClister D.M., Sweterlitsch S.E., Thompson R.P., et al. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms. Circulation 110 Suppl (2004) II268-II273
21. Eskandari M.K., Vijungco J.D., Flores A., Borensztajn J., Shively V., and Pearce W.H. Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res 123 (2005) 289-293
22. Barbour J.R., Stroud R.E., Lowry A.S., Clark L.L., Leone A.M., Jones J.A., et al. Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation. J Thorac Cardiovasc Surg 132 (2006) 788-795
23. Cho J.S., Haider S.E., and Makaroun M.S. US multicenter trials of endoprostheses for the endovascular treatment of descending thoracic aneurysms. M.D. J Vasc Surg 43 Suppl A (2006) 12A-19A
24. Stavropoulos S.W., and Carpenter J.P. Postoperative imaging surveillance and endoleak management after endovascular repair of thoracic aortic aneurysms. J Vasc Surg 43 Suppl A (2006) 12A-19A
25. Fattori R., Nienaber C.A., Rousseau H., Beregi J.P., Heijmen R., Grabenwoger M., et al. Talent Thoracic Retrospective Registry. Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: the Talent Thoracic Retrospective Registry. J Thorac Cardiovasc Surg 132 (2006) 332-339